
Core Points - Rosen Law Firm is reminding investors who purchased common stock of Orthofix Medical Inc. between October 11, 2022, and September 12, 2023, about the lead plaintiff deadline of October 21, 2024 [1] - Investors may be entitled to compensation through a contingency fee arrangement without any out-of-pocket costs [1] - A class action lawsuit has been filed against Orthofix, alleging misleading statements and omissions regarding the company's business and management conduct [3] Company Details - The lawsuit claims that Orthofix's management engaged in inappropriate conduct, which was not disclosed to investors, leading to damages when the truth was revealed [3] - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [2] Next Steps for Investors - Investors interested in joining the class action can visit the provided link or contact the firm directly for more information [1][3] - It is noted that no class has been certified yet, and investors can choose their counsel or remain absent from the class [3]